Nobilis Health Expands Footprint to El Paso, TX

HOUSTON, Dec. 4, 2017 /PRNewswire/ -- Nobilis Health Corp. (NYSE American: HLTH) ("Nobilis" or the "Company") today announced the opening of an ambulatory surgery center in El Paso, Texas ("ASC") that will generate revenue through in network commercial payor contracts. The ASC has two operating rooms and two procedure rooms and will provide multispecialty services, including those offered under Nobilis' nine direct to consumer marketing brands. This ASC expands Nobilis' geographic reach into El Paso, Texas and will capture patients from the west Texas and New Mexico markets.

Kenneth Efird, Nobilis' President, stated, "Our historical experience in the market, strength of existing physician relationships and partners, and our ability to drive volume and revenue through our sales and marketing division will provide a strong foundation for success in El Paso. The ASC will operate under in network contracts with major commercial payors and is a continuation of our stated strategy to grow our portfolio with in network volume and revenue."

About Nobilis Health Corp

Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company, with 32 locations across Texas and Arizona, including 5 hospitals, 14 ambulatory surgery centers, and 13 multi-specialty clinics. In addition, Nobilis partners with 36 facilities across the country. Marketing nine independent brands, Nobilis deploys a unique patient acquisition strategy driven by proprietary, direct-to-consumer marketing technology, focusing on a specified set of procedures that are performed at its facilities by local physicians. Nobilis' business model connects patients with physicians to deliver the highest quality healthcare while enhancing physician practices within the Nobilis network.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner.

We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016, filed on March 14, 2017, as updated by other filings with the Securities and Exchange Commission.

Contact Information:

Tuan Tran
Vice President, Investor Relations
(346) 207-6342
[email protected]

SOURCE Nobilis Health Corp.

Related Links

http://www.nobilishealth.com